Literature DB >> 18305466

Free p-cresol is associated with cardiovascular disease in hemodialysis patients.

B K I Meijers1, B Bammens, B De Moor, K Verbeke, Y Vanrenterghem, P Evenepoel.   

Abstract

Cardiovascular disease (CVD) is highly prevalent in chronic kidney disease, suggesting that molecules retained in uremia might contribute to this increased risk. We explored the relationship between p-cresol, a protein-bound uremic retention solute, and CVD by comparing the strength of this relationship relative to traditional and novel cardiovascular risk factors. Univariate Cox proportional hazard analysis showed that the free serum p-cresol concentration was significantly associated with CVD when the primary end point was the time to the first cardiovascular event. In multivariate analysis, free p-cresol was significantly associated with CVD in non-diabetics. In diabetic patients, however, a significant relationship between p-cresol and cardiovascular events could not be demonstrated despite their having significantly higher p-cresol levels. Our study shows that free p-cresol is a novel cardiovascular risk factor in non-diabetic hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305466     DOI: 10.1038/ki.2008.31

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  101 in total

1.  Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes?

Authors:  Raymond Vanholder; Natalie Meert; Wim Van Biesen; Timothy Meyer; Thomas Hostetter; Annemieke Dhondt; Sunny Eloot
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-23

2.  Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.

Authors:  Liesbeth Viaene; Björn K I Meijers; Bert Bammens; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Perit Dial Int       Date:  2013-10-31       Impact factor: 1.756

Review 3.  Uremic Toxins - Novel Arrhythmogenic Factor in Chronic Kidney Disease - Related Atrial Fibrillation.

Authors:  Shih-Yu Huang; Yi-Ann Chen; Shih-Ann Chen; Yi-Jen Chen; Yung-Kuo Lin
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

4.  Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.

Authors:  Tariq Shafi; Tammy L Sirich; Timothy W Meyer; Thomas H Hostetter; Natalie S Plummer; Seungyoung Hwang; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  Kidney Int       Date:  2017-07-21       Impact factor: 10.612

Review 5.  Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials.

Authors:  L Chiavaroli; A Mirrahimi; J L Sievenpiper; D J A Jenkins; P B Darling
Journal:  Eur J Clin Nutr       Date:  2014-11-12       Impact factor: 4.016

Review 6.  Enhancing dialyser clearance-from target to development.

Authors:  Kamonwan Tangvoraphonkchai; Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2017-04-12       Impact factor: 3.714

7.  Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.

Authors:  Matthew B Rivara; Leila R Zelnick; Andrew N Hoofnagle; Rick Newitt; Russell P Tracy; Mario Kratz; David S Weigle; Bryan R Kestenbaum
Journal:  Clin Chem       Date:  2017-02-10       Impact factor: 8.327

Review 8.  Searching for uremic toxins.

Authors:  Mirela Dobre; Timothy W Meyer; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 9.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

10.  p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Authors:  Björn K I Meijers; Henriette De Loor; Bert Bammens; Kristin Verbeke; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.